{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:30:43Z","timestamp":1773307843849,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/maj.0b013e31820ff7af","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T03:22:32Z","timestamp":1300245752000},"page":"504-507","source":"Crossref","is-referenced-by-count":12,"title":["Autoimmune Polyglandular Syndrome Type 2 Induced by Treatment With Interferon Alpha"],"prefix":"10.1016","volume":"341","author":[{"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Boldys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boguslaw","family":"Okopien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2010.40","article-title":"Autoimmune polyglandular syndromes","volume":"6","author":"Michels","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0015","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJMra030158","article-title":"Autoimmune polyendocrine syndromes","volume":"350","author":"Eisenbarth","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0020","first-page":"9","article-title":"Update on autoimmune polyendocrine syndromes (APS)","volume":"74","author":"Betterle","year":"2003","journal-title":"Acta Biomed"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2004.02561.x","article-title":"Autoimmune polyglandular syndrome Type 2: the tip of an iceberg?","volume":"137","author":"Betterle","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0030","first-page":"193","article-title":"Autoimmunity in isolated Addison\u2019s disease and in polyglandular autoimmune diseases type 1, 2 and 4","volume":"62","author":"Betterle","year":"2001","journal-title":"Ann Endocrinol"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-09-0044","article-title":"Polyglandular autoimmune syndromes","volume":"161","author":"Kahaly","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.beem.2009.07.004","article-title":"Interferon induced thyroiditis","volume":"23","author":"Tomer","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/S1413-86702008000200009","article-title":"Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin\u2014a review","volume":"12","author":"Andrade","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.0306-5251.2003.01854.x","article-title":"A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy","volume":"56","author":"Sasso","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0055","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2169\/internalmedicine.49.3831","article-title":"A case of type 1 diabetes onset and recurrence of Graves\u2019 disease during pegylated interferon-alpha plus ribavirin treatment for chronic hepatitis C","volume":"49","author":"Fujioka","year":"2010","journal-title":"Intern Med"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/BOR.0b013e3283368099","article-title":"Interferon therapy in rheumatic diseases: state-of-the-art 2010","volume":"22","author":"K\u00f6tter","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.beem.2008.09.004","article-title":"Pathogenesis of primary adrenal insufficiency","volume":"23","author":"Husebye","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","author":"Betterle","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0075","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1749-6632.1971.tb46921.x","article-title":"Factors influencing the rate of metabolism of steroid hormones in man","volume":"179","author":"Lipsett","year":"1971","journal-title":"Ann N Y Acad Sci"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0080","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(10)60355-8","article-title":"Primary ovarian insufficiency","volume":"376","author":"De Vos","year":"2010","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e31820ff7af_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0609.2005.00459.x","article-title":"Female fertility after cytotoxic therapy\u2014protection of ovarian function during chemotherapy of malignant and non-malignant diseases","volume":"66","author":"Mattle","year":"2005","journal-title":"Eur J Haematol Suppl"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915312751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915312751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T20:28:14Z","timestamp":1543868894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915312751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0002962915312751"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31820ff7af","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}